Alipay+ Partners with Global Brands in #MoneyCannotBuy Initiative to Attract E-Wallet Users across Asia
Alipay+ today launches the #MoneyCannotBuy marketing initiative, a series of social media campaigns and special rewards, as the provider of cross-border digital payments and marketing solutions teams with global merchants in bringing a unique travel experience to Asia’s e-wallet users.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230928554669/en/
With the debut treat unveiled in Dubai, a group of lucky e-wallet users would win round-trip flights in Dubai to find out the poems they submitted through an earlier Alipay+ social media campaign are projected onto the Burj Khalifa to light up the sky. (Photo: Business Wire)
#MoneyCannotBuy features major social media campaigns and special promotion from over 100 brands worldwide ranging from major theme parks to shopping malls, luxury retailers and major airports, for mobile-savvy travelers.
In China and beyond, travelers are seeking more memorable and unique travel experiences overseas. As part of the #MoneyCannotBuy campaign, Alipay+ is also hosting some 30 lucky e-wallet users from Malaysia, South Korea and Thailand on a Dream Tour, to share the excitement of the Asian Games and experience using their home e-wallets in China.
In-app offers for Alipay and other major e-wallet users
The initiative comes as Alipay+ has unveiled a series of special promotions for consumers globally, including Alipay users, for China’s longest public holiday, also known as Golden Week, which bridges over to fall and winter travel seasons.
On top of the #MoneyCannotBuy partner deals, Alipay users can also enjoy in-app car rental services across 200 countries and regions, extra 20% tax refund from major retailers in France, Italy and Spain, as well as other promotions offered by global merchants and tourism agencies.
Paralleled promotion and offers are also available to users of other Alipay+ partner e-wallets, including AlipayHK (Hong Kong SAR, China), GCash (The Philippines), TrueMoney (Thailand) and Touch ‘n Go eWallet among others. The offers range from coupons and free milk tea at Printemps in Paris to 10% off at Seoul's Noryangjin Fish Market.
2023 has been a year of major breakthroughs for Alipay+. Created as a suite of cross-border mobile payment and marketing solutions by Ant Group, Alipay+ now works with about 30 leading e-wallets. With its recent extension into the Chinese mainland, the service now connects tens of millions of merchants in 56 markets to over 1.4 billion payment accounts in Asia and beyond. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
Alipay+ outbound tourism campaign this fall debuts in Dubai with Mid-Autumn rewards
As one of Chinese travelers’ new favorite destinations, Dubai’s downtown shopping malls, such as Galeries Lafayette, Bloomingdale's and Harvey Nichols, are rolling out 15-30% discounts to attract Chinese consumers. Alipay users can also enjoy perks like free massage from Galeries Lafayette when they book a session through the app.
A group of lucky e-wallet users from Alipay, AlipayHK (Hong Kong SAR China), Mpay (Macao SAR China) and OCBC (Singapore) even won round-trip flights and accommodation in Dubai. They also found the poems they submitted through an earlier Alipay+ social media campaign projected onto the 828-metre commanding Burj Khalifa to light up the sky.
The poems are presented alongside a 3-minute branding video of Alipay+ at the world’s tallest building in celebration of the Mid-Autumn Festival, a traditional festival of family and friends’ reunion under the full moon. The video showcases the importance of connectedness and heart-to-heart reunion through the lens of a rabbit traveling around the world in search of the moon.
The same branding video and poems will also be featured spontaneously at Aurora Plaza and Citibank Plaza on the Bund in Shanghai. For more fun, an underground train in Hangzhou has been revamped as a time tunnel to various hot destinations to mark the embarkment of the Golden Week and the #MoneyCannotBuy campaign.
“With a potential reach of over 1.4 billion consumers with increasing demand for unique travel and shopping experiences, we believe Alipay+ is in the best position to offer an omni-channel and pool resources with our merchants and digital payments partners,” said Dr Cherry Huang, General Manager of Alipay+ Offline Merchant Services at Ant Group. “We hope more businesses can take part in the initiative to help deliver the best #MoneyCannotBuy experiences to consumers and unleash more growth through innovation and collaboration.”
About Alipay+
Alipay+ is a suite of cross-border digital payment, marketing and digitalization solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230928554669/en/
Contact information
Media
Sarah Dai
Ant Group
Sarah.dai@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom